Sarah Sammons
- Oncology top 5%
- HER2/EGFR in Cancer Research 22
- Cancer Treatment and Pharmacology 21
- Lung Cancer Research Studies 15
-
- Advanced Breast Cancer Therapies 40
- Brain Metastases and Treatment 20
- Lung Cancer Treatments and Mutations 9
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 17
- Breast Cancer Treatment Studies 15
- Otorhinolaryngology top 10%
- Genetics top 10%
- Co-authors
- Kimberly BlackwellCarey K. AndersSara M. TolaneyAmanda E.D. Van SwearingenErika HamiltonAdam RabenNancy U. LinRobert L. Witt
- Journals
- Journal of Clinical Oncology (23 papers)JNCI Journal of the National Cancer Institute (2 papers)Cancer Research (15 papers)
- Partner nations
- United StatesItalyFrance
In The Last Decade
Sarah Sammons
79 papers receiving 699 citations
Peers
Comparison fields: 5 of 57
- Oncology 466
- Pulmonary and Respiratory Medicine 399
- Cancer Research 168
- Otorhinolaryngology 40
- Genetics 97
Countries citing papers authored by Sarah Sammons
This map shows the geographic impact of Sarah Sammons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Sammons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Sammons more than expected).
Fields of papers citing papers by Sarah Sammons
This network shows the impact of papers produced by Sarah Sammons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Sammons. The network helps show where Sarah Sammons may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sarah Sammons, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 4 | |
| 3 | 2025 | 4 | |
| 4 | 2025 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 9 | |
| 7 | 2024 | 3 | |
| 8 | 2024 | 4 | |
| 9 | 2023 | 24 | |
| 10 | 2023 | 21 | |
| 11 | 2023 | 9 | |
| 12 | 2023 | 4 | |
| 13 | 2023 | 2 | |
| 14 | 2023 | 3 | |
| 15 | 2021 | 10 | |
| 16 | 2020 | 27 | |
| 17 | 2020 | 10 | |
| 18 | 2020 | 5 | |
| 19 | 2020 | 5 | |
| 20 | 2018 | 14 |
About Sarah Sammons
Sarah Sammons is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 92 papers that have together received 706 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (40 papers), HER2/EGFR in Cancer Research (22 papers), Cancer Treatment and Pharmacology (21 papers), Brain Metastases and Treatment (20 papers), Cancer Genomics and Diagnostics (17 papers), Lung Cancer Research Studies (15 papers), Breast Cancer Treatment Studies (15 papers) and Lung Cancer Treatments and Mutations (9 papers). The work is most often cited by research in Oncology (466 citations), Pulmonary and Respiratory Medicine (399 citations) and Cancer Research (168 citations). Sarah Sammons has collaborated with scholars based in United States, Italy and France. Frequent co-authors include Kimberly Blackwell, Carey K. Anders, Sara M. Tolaney, Amanda E.D. Van Swearingen, Erika Hamilton, Adam Raben, Nancy U. Lin, Robert L. Witt, Romualdo Barroso‐Sousa and Charles Schneider. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.